The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes.
David R RileyTheresa J HydesGema HernadezSizheng S ZhaoUazman AlamDaniel J CuthbertsonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
T2D significantly potentiates the risk of cardiovascular, malignancy and liver-related outcomes in people with MASLD. The effect of MASLD on people with T2D, although less dramatic, still potentiated risk of death, IHD, malignancy and peripheral neuropathy.